Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: When does L-T 4 therapy become mandatory?

Silvia Porretti, Claudia Giavoli, Cristina Ronchi, Gaetano Lombardi, Marco Zaccaria, Domenico Valle, Maura Arosio, Paolo Beck-Peccoz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: When does L-T 4 therapy become mandatory?'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences